nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2005-9-4-13-18nefr-708Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESСОВРЕМЕННЫЕ КОНВЕКЦИОННЫЕ МЕТОДЫ ТЕРАПИИ БОЛЬНЫХ С ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ. СООБЩЕНИЕ IIMODERN CONVECTION METHODS OF THERAPY OF CHRONIC RENAL FAILURE PATIENTS. COMMUNICATION IIГубарьН. Я.GubarN. Ya.

Кафедра пропедевтики внутренних болезней

СмирновА. В.SmirnovA. V.

Кафедра пропедевтики внутренних болезней

СуглобоваЕ. Д.SuglobovaE. D.

Кафедра пропедевтики внутренних болезней

Санкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаRussian Federation200510042005941318Copyright © Губарь Н.Я., Смирнов А.В., Суглобова Е.Д., 20052005Губарь Н.Я., Смирнов А.В., Суглобова Е.Д.Gubar N.Y., Smirnov A.V., Suglobova E.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/708

Современные конвекционные методы терапии больных с хронической почечной недостаточностью. Сообщение II.

Modern convection methods of therapy of chronic renal failure patients. Communication II.

ГемодиафильтрациягемодиализамилоидозанемияhemodiafiltrationhemodialysisamyloidosisanemiaReferencesГубарь НЯ, Смирнов АВ, Суглобова ЕД. Современные конвекционные методы терапии больных с хронической по чечной недостаточностью. Сообщение 1. Нефрология, 2005; 9(2):4248Губарь НЯ, Смирнов АВ, Суглобова ЕД. Современные конвекционные методы терапии больных с хронической по чечной недостаточностью. Сообщение 1. Нефрология, 2005; 9(2):4248Maggiore Q, Pizzarelli F, Dattolo P et al. Cardiovascular stability during haemodialysis, haemofiltration and haemodiafiltration. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 68–73Maggiore Q, Pizzarelli F, Dattolo P et al. Cardiovascular stability during haemodialysis, haemofiltration and haemodiafiltration. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 68–73Pizzarelli F, Maggiore Q. Clinical perspectives of online haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 34–37Pizzarelli F, Maggiore Q. Clinical perspectives of online haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 34–37Altieri P, Sorba G, Bolasco PG et al. Online predilution hemofiltration vs ultrapure highflux hemodialysis. Blood Purif 1997; 15:169181Altieri P, Sorba G, Bolasco PG et al. Online predilution hemofiltration vs ultrapure highflux hemodialysis. Blood Purif 1997; 15:169181Altieri P, Sorba G, Bolasco P et al. Predilution haemofiltration—the Sardinian multicentre studies: present and future. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 55–59Altieri P, Sorba G, Bolasco P et al. Predilution haemofiltration—the Sardinian multicentre studies: present and future. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 55–59Locatelli F, Mastrangelo F, Redaelli B et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 1996; 50:12931302Locatelli F, Mastrangelo F, Redaelli B et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 1996; 50:12931302Kissinger GL, Dellanna F, Upsing L et al. Homocysteine kinetics in postdilution hemodiafiltration with two different dialysate flow compared to hemodialysis. Nephrol Dial Transplant 2000; 15(9): A221Kissinger GL, Dellanna F, Upsing L et al. Homocysteine kinetics in postdilution hemodiafiltration with two different dialysate flow compared to hemodialysis. Nephrol Dial Transplant 2000; 15(9): A221Nakanishi K, Hirasawa H, Sugai T et al. Efficacy of continuous hemodiafiltration for patient with congestive heart failure. Blood Purif 2002; 20(4): 342348Nakanishi K, Hirasawa H, Sugai T et al. Efficacy of continuous hemodiafiltration for patient with congestive heart failure. Blood Purif 2002; 20(4): 342348Maduell F, del Pozo1 C, Garcia H. Change from conventional haemodiafiltration to online haemodiafiltration. Nephrol Dial Transplant 1999; 14: 1202–1207Maduell F, del Pozo1 C, Garcia H. Change from conventional haemodiafiltration to online haemodiafiltration. Nephrol Dial Transplant 1999; 14: 1202–1207Рыбакова ОБ, Денисов АЮ, Шило ВЮ. Гемодиафиль трация в лечении терминальной стадии хронической по чечной недостаточности. Нефрология и диализ 2001; 3(4): 406410Рыбакова ОБ, Денисов АЮ, Шило ВЮ. Гемодиафиль трация в лечении терминальной стадии хронической по чечной недостаточности. Нефрология и диализ 2001; 3(4): 406410Рыбакова ОБ, Денисов АЮ, Шило ВЮ. Эффектив ность гемодиализа и гемодиафильтрации online в лече нии анемии у больных с терминальной ХПН. Нефрология 2003; 7 [приложение 1]: 347Рыбакова ОБ, Денисов АЮ, Шило ВЮ. Эффектив ность гемодиализа и гемодиафильтрации online в лече нии анемии у больных с терминальной ХПН. Нефрология 2003; 7 [приложение 1]: 347Lin CL, Huang CC, Yu CC et al. Improved iron utilization and reduced erythropoietin resistance by online hemodiafiltration. Blood Purif 2002; 20(4): 349356Lin CL, Huang CC, Yu CC et al. Improved iron utilization and reduced erythropoietin resistance by online hemodiafiltration. Blood Purif 2002; 20(4): 349356Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 1975; 51(597):4502Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 1975; 51(597):4502Gejyo F, Homma N, Suzuki Y, Arakawa M. Serum levels of beta 2microglobulin as a new form of amyloid protein in patients undergoing longterm hemodialysis. N Engl J Med 1986; 27(9):5856Gejyo F, Homma N, Suzuki Y, Arakawa M. Serum levels of beta 2microglobulin as a new form of amyloid protein in patients undergoing longterm hemodialysis. N Engl J Med 1986; 27(9):5856Gejyo F, Odani S, Yamada T et al. Beta 2microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30(3): 38590Gejyo F, Odani S, Yamada T et al. Beta 2microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30(3): 38590Gejyo F. Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities—uremic toxin, middle and large molecular substances. Nippon Naika Gakkai Zasshi 1986; 75(11):15504Gejyo F. Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities—uremic toxin, middle and large molecular substances. Nippon Naika Gakkai Zasshi 1986; 75(11):15504Drueke TB. b2Microglobulin and amyloidosis. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 17–24Drueke TB. b2Microglobulin and amyloidosis. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 17–24Locatelli F, Di Filippo S, Manzoni C. Removal of small and middle molecules by convective techniques. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 37–44Locatelli F, Di Filippo S, Manzoni C. Removal of small and middle molecules by convective techniques. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 37–44Lornoy W, Becaus I, Billiouw JM et al. Online haemodiafiltration. Remarkable removal of b2microglobulin. Longterm clinical observations. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 49–54Lornoy W, Becaus I, Billiouw JM et al. Online haemodiafiltration. Remarkable removal of b2microglobulin. Longterm clinical observations. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 49–54Nakai S, Iseki K, Tabei K et al. Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis 2001; 38 [Suppl. 1]: S212216Nakai S, Iseki K, Tabei K et al. Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis 2001; 38 [Suppl. 1]: S212216Locatelli F, Marucelli D, Conte F et al. Comparison of mortality in ESRD patient on convective and diffusive extracorporeal treatments. Kidney Int 1999; 155: 286293Locatelli F, Marucelli D, Conte F et al. Comparison of mortality in ESRD patient on convective and diffusive extracorporeal treatments. Kidney Int 1999; 155: 286293Bricker NS, Slatopolsky E, Reiss E, Avioli LV. Calcium, phosphorus and bone in renal disease and transplantation. Arch Intern Med 1969; 123:543–553Bricker NS, Slatopolsky E, Reiss E, Avioli LV. Calcium, phosphorus and bone in renal disease and transplantation. Arch Intern Med 1969; 123:543–553Drueke TB. Renal osteodystrophy: management of hyperphosphataemia. Nephrol Dial Transplant 2000; 15, [Suppl. 5]: S32S34Drueke TB. Renal osteodystrophy: management of hyperphosphataemia. Nephrol Dial Transplant 2000; 15, [Suppl. 5]: S32S34Massry SG, Coburn JW, Hartenbower DL et al. Mineral content of human skin in uraemia. Effect of secondary hyperparathyroidism and haemodialysis. Proc Eur Dial Transplant Assoc 1970; 7: 146 148Massry SG, Coburn JW, Hartenbower DL et al. Mineral content of human skin in uraemia. Effect of secondary hyperparathyroidism and haemodialysis. Proc Eur Dial Transplant Assoc 1970; 7: 146 148Vanholder RC, Glorieux GL, De Smet RV. Uremic toxins: Removal with different therapies. Hemodial Int 2003; 7(2):162– 167Vanholder RC, Glorieux GL, De Smet RV. Uremic toxins: Removal with different therapies. Hemodial Int 2003; 7(2):162– 167Vanholder RC, Glorieux GL, De Smet RV. Back to the future: middle molecules, high flux membranes, and optimal dialysis. Hemodial Int 2003; 7(1):52–57Vanholder RC, Glorieux GL, De Smet RV. Back to the future: middle molecules, high flux membranes, and optimal dialysis. Hemodial Int 2003; 7(1):52–57Chanard J, Brunois IP, Melin JP et al. Longterm result of dialysis therapy with a highly permeable membrane. Artif Organs 1982; 6:261266Chanard J, Brunois IP, Melin JP et al. Longterm result of dialysis therapy with a highly permeable membrane. Artif Organs 1982; 6:261266WoodsHF, Nandakumar M. Improved outcome for haemodialysis patients treated with highflux membranes. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 36–42WoodsHF, Nandakumar M. Improved outcome for haemodialysis patients treated with highflux membranes. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 36–42Locatelli F, Marucelli D, Conte F et al. Comparison of mortality in ESRD patient on convective and diffusive extracorporeal treatments. Kidney Int 1999; 155: 286293Locatelli F, Marucelli D, Conte F et al. Comparison of mortality in ESRD patient on convective and diffusive extracorporeal treatments. Kidney Int 1999; 155: 286293Port FK, Wolfe RA, HulbertShearon TE et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001; 37: 276286Port FK, Wolfe RA, HulbertShearon TE et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001; 37: 276286Carlo Basile. The effect of convection on the nutritional status of haemodialysis patients. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii46–vii49Carlo Basile. The effect of convection on the nutritional status of haemodialysis patients. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii46–vii49Gutierrez A, Bergstrom J, Alvestrand A. Protein catabolism in sham hemodialysis: the effect of different membranes. Clin Nephrol 1992; 38:2029Gutierrez A, Bergstrom J, Alvestrand A. Protein catabolism in sham hemodialysis: the effect of different membranes. Clin Nephrol 1992; 38:2029Locatelli F, Andrulli S, Pedrini L et al. Effect of highflux dialysis on the anemia of hemodialysis patients. Nephrol Dial Transplant 2000; 15:13991409Locatelli F, Andrulli S, Pedrini L et al. Effect of highflux dialysis on the anemia of hemodialysis patients. Nephrol Dial Transplant 2000; 15:13991409Locatelli F, Manzoni C, Di Filippo S, Andrulli S. Online monitoring and convective treatment modalities: shortterm advantages. Nephrol Dial Transplant 1999;14 [Suppl 3]: 927Locatelli F, Manzoni C, Di Filippo S, Andrulli S. Online monitoring and convective treatment modalities: shortterm advantages. Nephrol Dial Transplant 1999;14 [Suppl 3]: 927Wizemann V, Lotz C, Techert F, Utho S. Online haemodiafiltration versus lowflux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 43–48Wizemann V, Lotz C, Techert F, Utho S. Online haemodiafiltration versus lowflux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 43–48Locatelli F, Manzoni C, di Filippo S. The importance of convective transport. Kidney Int 2002; 61 [Suppl 80]: S115– S120Locatelli F, Manzoni C, di Filippo S. The importance of convective transport. Kidney Int 2002; 61 [Suppl 80]: S115– S120Cappelli G, Perrone S, CiuVreda A. Water quality for online haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 12–16Cappelli G, Perrone S, CiuVreda A. Water quality for online haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 12–16Canaud B, Bosc JY, Leray H, Stec F. Microbiological purity of dialysate for online substitution fluid preparation. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 21–30Canaud B, Bosc JY, Leray H, Stec F. Microbiological purity of dialysate for online substitution fluid preparation. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 21–30Lonnemann G. Should ultrapure dialysate be mandatory? Nephrol Dial Transplant 2000; 15 [Suppl 1]: 55–59Lonnemann G. Should ultrapure dialysate be mandatory? Nephrol Dial Transplant 2000; 15 [Suppl 1]: 55–59Pontoriero G, Pozzoni P, Andrulli S, Locatelli F. The quality of dialysis water. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii21–vii25Pontoriero G, Pozzoni P, Andrulli S, Locatelli F. The quality of dialysis water. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii21–vii25Brunet P, Berland Y. Water quality and complications of haemodialysis. Nephrol Dial Transplant 2000; 15: 578580Brunet P, Berland Y. Water quality and complications of haemodialysis. Nephrol Dial Transplant 2000; 15: 578580Surian M, Bonforte G, Scanziani R et al. Trace elements and micropollutant anions in the dialysis and reinfusion fluid prepared online for haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 24–28Surian M, Bonforte G, Scanziani R et al. Trace elements and micropollutant anions in the dialysis and reinfusion fluid prepared online for haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 24–28Canaud B, Bosc JY, LerayMoragues H et al. Online haemodiafiltration. Safety and efficacy in longterm clinical practice. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 60–67Canaud B, Bosc JY, LerayMoragues H et al. Online haemodiafiltration. Safety and efficacy in longterm clinical practice. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 60–67Combarnous F, Tetta C, Cellier CC et al. Albumin loss in online hemodiafiltration. Int J Artif Organs 2002; 25(3): 2039Combarnous F, Tetta C, Cellier CC et al. Albumin loss in online hemodiafiltration. Int J Artif Organs 2002; 25(3): 2039

The authors declare that there are no conflicts of interest present.